- Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.
- Dexcom Announces Upcoming Conference Presentations
- DexCom Promotes Jake Leach to Chief Operating Officer
- Dexcom Announces Upcoming Conference Presentation
- Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes
- Dexcom Reports Second Quarter 2022 Financial Results
- Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
- Dexcom Canada Achieves Great Place to Work® Certification
Dexcom Inc (DC4:STU) closed at 80.93, 27.39% above the 52 week low of 63.53 set on Jun 16, 2022.
63.53Jun 16 2022144.90Nov 16 2021
Markit short selling activity
|Market cap||31.54bn USD|
|EPS (TTM)||0.4741 |
Data delayed at least 15 minutes, as of Oct 03 2022.